Shares of Acasti Pharma Inc. (CVE:ACST – Get Free Report) traded up 1.8% on Wednesday . The company traded as high as C$0.58 and last traded at C$0.58. 2,450 shares were traded during mid-day trading, a decline of 63% from the average session volume of 6,576 shares. The stock had previously closed at C$0.57.
Acasti Pharma Stock Performance
The business’s fifty day moving average is C$0.58 and its two-hundred day moving average is C$0.58. The stock has a market capitalization of C$25.87 million, a PE ratio of -1.07 and a beta of 1.22. The company has a quick ratio of 9.41, a current ratio of 9.74 and a debt-to-equity ratio of 0.52.
Acasti Pharma Company Profile
Acasti Pharma Inc, a biopharmaceutical company, engages in the development and commercialization of pharmaceutical products for cardiovascular diseases. It is evaluating strategic partnerships for the clinical development of CaPre. The company was incorporated in 2002 and is headquartered in Laval, Canada.
Further Reading
- Five stocks we like better than Acasti Pharma
- Uptrend Stocks Explained: Learn How to Trade Using Uptrends
- Microsoft Stock Gets a $550 Price Target: Time to Get Excited
- What is the Nikkei 225 index?
- Trump Tariffs in Focus: 2 Chinese Stocks to Own and 2 to Avoid
- What is the Dogs of the Dow Strategy? Overview and Examples
- 2 Generic Drug Stocks Ready to Surge in 2025
Receive News & Ratings for Acasti Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acasti Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
